Regeneron Pharmaceuticals stock price
리제네론 파머슈티컬스NASDAQ:REGN · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Regeneron Pharmaceuticals last closed at $735.20 (+0.05%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 18.1×. Its overall grade ranks 154 of 739 stocks in Healthcare.
About this company
Regeneron Pharmaceuticals last closed at $735.20 (+0.05%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 154/739
Valuation grade D
Dividends
2025 dividend per share · $3.52 · Yield 0.48%
Details →Related stocks
- SanofiCompetitor
아토피/면역질환 등 공동개발 후 사업 이해관계가 겹치는 주요 경쟁·협력사
- AstraZenecaCompetitor
호흡기·면역·안과 등 혁신 바이오 영역에서 직접 경쟁하는 글로벌 제약사
- NovartisCompetitor
안과·면역·희귀질환 치료제 분야에서 경쟁하는 대형 제약사
ETFs holding this stock
VanEck Biotech ETF · iShares Biotechnology ETF · Invesco Nasdaq Biotechnology ETF
Details →About Regeneron Pharmaceuticals
- What technical signals does Regeneron Pharmaceuticals (REGN) have?
- Regeneron Pharmaceuticals current technical signals: no active technical signal.
- Is Regeneron Pharmaceuticals a cup-and-handle pattern?
- No. Regeneron Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Regeneron Pharmaceuticals?
- Market cap: $77.55B. Trailing 12 months PER: 18.1×. Latest quarter PBR: 2.48×. Dividend yield: 0.48%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Regeneron Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).